- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Covalent)(Non-covalent)
- 2 x CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID(Non-covalent)
CB3.2: 14 residues within 4Å:- Chain A: A.285, E.292, I.313, N.317, D.424, L.427, G.428, F.431, N.432, Y.464, M.515, M.517, A.518
- Ligands: UMP.1
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:I.313, A:I.313, A:F.431
- Hydrogen bonds: A:A.518, A:A.518, A:A.518
- Water bridges: A:K.282, A:K.282, A:G.288
- Salt bridges: A:K.282, A:D.424
- pi-Stacking: A:F.431
CB3.6: 14 residues within 4Å:- Chain B: A.285, E.292, I.313, W.314, N.317, D.424, L.427, G.428, F.431, N.432, Y.464, M.517, A.518
- Ligands: UMP.5
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.313, B:I.313, B:F.431
- Hydrogen bonds: B:A.518, B:A.518, B:A.518
- Salt bridges: B:K.282, B:D.424
- pi-Stacking: B:W.314, B:F.431
- 2 x MTX: METHOTREXATE(Non-covalent)
MTX.3: 17 residues within 4Å:- Chain A: V.7, V.8, A.9, L.23, D.30, L.31, K.32, F.34, S.35, T.56, I.60, L.65, R.68, C.111, Y.117, T.132
- Ligands: NDP.4
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:L.31, A:F.34, A:F.34, A:I.60
- Hydrogen bonds: A:C.111, A:T.132, A:T.132
- Water bridges: A:V.8, A:T.132
- Salt bridges: A:D.30, A:R.68
- pi-Stacking: A:F.34
MTX.7: 17 residues within 4Å:- Chain B: V.7, V.8, A.9, L.23, D.30, L.31, K.32, F.34, S.35, T.56, I.60, L.65, R.68, C.111, Y.117, T.132
- Ligands: NDP.8
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:L.31, B:I.60
- Hydrogen bonds: B:C.111, B:T.132, B:T.132
- Water bridges: B:K.32, B:K.32, B:T.132, B:T.132
- Salt bridges: B:D.30, B:K.32, B:R.68
- pi-Stacking: B:F.34, B:F.34
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.4: 27 residues within 4Å:- Chain A: V.8, A.9, I.17, G.18, I.19, G.21, Q.22, L.23, G.53, R.54, K.55, T.56, I.73, S.74, S.75, S.76, R.90, C.111, G.112, G.113, E.114, S.115, I.116, Y.117, D.119, T.143
- Ligands: MTX.3
26 PLIP interactions:26 interactions with chain A- Hydrophobic interactions: A:I.17, A:L.23, A:T.56
- Hydrogen bonds: A:A.9, A:I.17, A:I.19, A:G.21, A:G.53, A:R.54, A:K.55, A:T.56, A:S.74, A:S.75, A:S.76, A:G.112, A:E.114, A:S.115, A:S.115, A:I.116, A:Y.117, A:D.119, A:T.143, A:T.143
- Water bridges: A:K.55, A:S.59
- Salt bridges: A:R.54
NDP.8: 26 residues within 4Å:- Chain B: V.8, A.9, I.17, G.18, G.21, Q.22, L.23, G.53, R.54, K.55, T.56, I.73, S.74, S.75, S.76, R.90, C.111, G.112, G.113, E.114, S.115, I.116, Y.117, D.119, T.143
- Ligands: MTX.7
24 PLIP interactions:24 interactions with chain B- Hydrophobic interactions: B:L.23
- Hydrogen bonds: B:A.9, B:I.17, B:I.19, B:G.21, B:G.21, B:G.53, B:R.54, B:K.55, B:T.56, B:T.56, B:S.74, B:S.75, B:S.76, B:G.112, B:E.114, B:S.115, B:S.115, B:I.116, B:Y.117, B:D.119, B:T.143
- Water bridges: B:T.143
- Salt bridges: B:R.54
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Doan, L.T. et al., Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis. Biochemistry (2007)
- Release Date
- 2007-07-17
- Peptides
- Chain A, crystal structure of Dhfr: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Covalent)(Non-covalent)
- 2 x CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID(Non-covalent)
- 2 x MTX: METHOTREXATE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Doan, L.T. et al., Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis. Biochemistry (2007)
- Release Date
- 2007-07-17
- Peptides
- Chain A, crystal structure of Dhfr: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B